Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (221-230 of 3,133) with videos related to

Pageof 314
Sort By:
Cytotherapy|July 3, 2021
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemiaSijie Lu, Eran Tallis, Xiaoling Ding, et al.
Cytotherapy|June 13, 2021
Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectorsPeter Chockley, Sagar L Patil, Stephen Gottschalk
Cytotherapy|June 12, 2021
Decisional tool for cost of goods analysis of bioartificial liver devices for routine clinical useJoana Mendonça da Silva, Christos Stamatis, Sherri-Ann Chalmers, et al.
Cytotherapy|May 24, 2022
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19<sup>+</sup> hematologic indicationsJeffrey Teoh, Lauren F Brown
Cytotherapy|October 28, 2003
A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCsF Bracho, C van de Ven, E Areman, et al.
Cytotherapy|October 28, 2003
Cryopreservation of cord blood after liquid storageA Hubel, D Carlquist, M Clay, et al.
Cytotherapy|October 28, 2003
Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impactJ N Lowder, P Whelton
Cytotherapy|October 28, 2003
Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategiesR Zweigerdt, M Burg, E Willbold, et al.
Cytotherapy|October 28, 2003
Collection of autologous PBSC in patients with polycythemia veraL Isola, M Gorsky, V Najfeld, et al.
Cytotherapy|July 10, 2003
Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facilityB J Grilley, A P Gee
Pageof 314

Showing results (221-230 of 3,133) with videos related to

Sort By:
Pageof 314
Cytotherapy|July 3, 2021
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemiaSijie Lu, Eran Tallis, Xiaoling Ding, et al.
Cytotherapy|June 13, 2021
Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectorsPeter Chockley, Sagar L Patil, Stephen Gottschalk
Cytotherapy|June 12, 2021
Decisional tool for cost of goods analysis of bioartificial liver devices for routine clinical useJoana Mendonça da Silva, Christos Stamatis, Sherri-Ann Chalmers, et al.
Cytotherapy|May 24, 2022
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19<sup>+</sup> hematologic indicationsJeffrey Teoh, Lauren F Brown
Cytotherapy|October 28, 2003
A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCsF Bracho, C van de Ven, E Areman, et al.
Cytotherapy|October 28, 2003
Cryopreservation of cord blood after liquid storageA Hubel, D Carlquist, M Clay, et al.
Cytotherapy|October 28, 2003
Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impactJ N Lowder, P Whelton
Cytotherapy|October 28, 2003
Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategiesR Zweigerdt, M Burg, E Willbold, et al.
Cytotherapy|October 28, 2003
Collection of autologous PBSC in patients with polycythemia veraL Isola, M Gorsky, V Najfeld, et al.
Cytotherapy|July 10, 2003
Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facilityB J Grilley, A P Gee
Pageof 314